Dr. Kelly Huang
Chief Operating Officer
Dr. Huang brings more than 25 years of diverse executive and operational experience in medical devices, services, health IT, and consumer health to Cardea. Prior to Cardea, Dr. Huang held the positions of COO and President of Nutri-Therapeutic at L-Nutra, where he supported a significant increase in sales and funding through the COVID-19 pandemic. Before this, he was CEO, President, and Board Director for Obalon Therapeutics, a publicly traded medical device company commercializing novel weight-loss technologies including delivery systems integrating electrical, mechanical, and sensing technologies. Through the previous decade, he held several management and executive roles leading development of multiple new technologies and commercial launches at Nestle Skin Health, Endo Health Solutions, and the Johnson & Johnson family of companies.